As most cMBCs expressed class-switched BCRs in all 3 study groups (Figure 5C), the lower proportion of switched MBCs in patients with IBD treated with anti-TNF overall may reflect the decreased frequency of cMBCs (Figure 2C), rather than a decrease in class switching. The gene discussed is TNF; the disease is inflammatory bowel disease.